FATE
Price
$0.94
Change
+$0.02 (+2.17%)
Updated
Aug 11, 01:55 PM (EDT)
Capitalization
105.62M
Earnings call today
ZNTL
Price
$1.44
Change
-$0.00 (-0.00%)
Updated
Aug 11, 11:15 AM (EDT)
Capitalization
103.88M
84 days until earnings call
Interact to see
Advertisement

FATE vs ZNTL

Header iconFATE vs ZNTL Comparison
Open Charts FATE vs ZNTLBanner chart's image
Fate Therapeutics
Price$0.94
Change+$0.02 (+2.17%)
Volume$200
Capitalization105.62M
Zentalis Pharmaceuticals
Price$1.44
Change-$0.00 (-0.00%)
Volume$345
Capitalization103.88M
FATE vs ZNTL Comparison Chart in %
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. ZNTL commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (FATE: $0.92 vs. ZNTL: $1.44)
Brand notoriety: FATE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 82% vs. ZNTL: 50%
Market capitalization -- FATE: $105.62M vs. ZNTL: $103.88M
FATE [@Biotechnology] is valued at $105.62M. ZNTL’s [@Biotechnology] market capitalization is $103.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 6 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 5 bearish.
  • ZNTL’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -13.89% price change this week, while ZNTL (@Biotechnology) price change was +7.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.72%. For the same industry, the average monthly price growth was +32.20%, and the average quarterly price growth was +19.30%.

Reported Earning Dates

FATE is expected to report earnings on Aug 11, 2025.

ZNTL is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+22.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($106M) and ZNTL($104M) have the same market capitalization . FATE YTD gains are higher at: -44.158 vs. ZNTL (-52.475). FATE has higher annual earnings (EBITDA): -168.28M vs. ZNTL (-199.29M). ZNTL has more cash in the bank: 332M vs. FATE (240M). ZNTL has less debt than FATE: ZNTL (38.7M) vs FATE (83.3M). ZNTL has higher revenues than FATE: ZNTL (26.9M) vs FATE (13.3M).
FATEZNTLFATE / ZNTL
Capitalization106M104M102%
EBITDA-168.28M-199.29M84%
Gain YTD-44.158-52.47584%
P/E RatioN/AN/A-
Revenue13.3M26.9M49%
Total Cash240M332M72%
Total Debt83.3M38.7M215%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEZNTL
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 20 days ago
86%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEGRF7.100.65
+10.14%
Pennon Group PLC
BBUZ0.05N/A
+5.29%
Bebuzee Inc.
CAXPF0.06N/A
N/A
District Copper Corp.
ALFDF7.39N/A
N/A
Astral Foods Ltd.
LFABF36.00N/A
N/A
Lifco AB

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with RXRX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-5.99%
RXRX - FATE
54%
Loosely correlated
-0.92%
ALLO - FATE
54%
Loosely correlated
-0.95%
CRBU - FATE
53%
Loosely correlated
-4.42%
NTLA - FATE
52%
Loosely correlated
-5.85%
CRSP - FATE
52%
Loosely correlated
-1.72%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-0.69%
NGNE - ZNTL
46%
Loosely correlated
-1.12%
FATE - ZNTL
45%
Loosely correlated
-5.99%
RXRX - ZNTL
45%
Loosely correlated
-0.92%
CRBU - ZNTL
44%
Loosely correlated
-4.42%
NTLA - ZNTL
44%
Loosely correlated
-5.85%
More